Corbadrine
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol | |
| Clinical data | |
| Legal status |
|
| Identifiers | |
| CAS Number |
829-74-3 |
| ATC code | none |
| PubChem | CID 164739 |
| IUPHAR/BPS | 508 |
| DrugBank |
DB06707 |
| ChemSpider |
144416 |
| UNII |
V008L6478D |
| KEGG |
D02388 |
| ChEMBL |
CHEMBL677 |
| Chemical data | |
| Formula | C9H13NO3 |
| Molar mass | 183.204 g/mol |
| |
| |
| | |
Corbadrine (INN; marketed as Neo-Cobefrine), also known as levonordefrin (USAN) and α-methylnorepinephrine, is a catecholamine sympathomimetic used as a topical nasal decongestant and vasoconstrictor in dentistry in the United States,[1][2] (usually in a pre-mixed solution with local anesthetics, such as mepivacaine).[3]
Corbadrine is also a metabolite of the antihypertensive drug methyldopa,[4] and plays a role in its pharmacology and effects.
See also
References
- ↑ Dr. Ian Morton; I.K. Morton; Judith M. Hall (31 October 1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 164–. ISBN 978-0-7514-0499-9.
- ↑ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 275–. ISBN 978-3-88763-075-1.
- ↑ "DailyMed — Search results for levonordefrin". DailyMed. Retrieved 20 February 2016.
- ↑ Sjoerdsma, A; Vendsalu, A; Engelman, K; Watts, D (1 October 1963). "Studies on the Metabolism and Mechanism of Action of Methyldopa". Circulation 28 (4): 492–502. doi:10.1161/01.CIR.28.4.492.
External links
- Nordefrin at the US National Library of Medicine Medical Subject Headings (MeSH)
| ||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
